- Compound Dexamethasone
- Class Immunomodulatory Agents
- Human Studies Yes
- FDA Approved Yes
Research is being conducted into the immunopathogenesis of COVID-19 and compounds that have immunomodulatory effects may be a therapeutic strategy.
Dexamethasone: a corticosteroid with anti-inflammatory properties that can be used for the treatment of COVID-19.
RELATED PROJECTS
